Integer Holdings Corporation (ITGR)
NYSE: ITGR · Real-Time Price · USD
102.10
+1.05 (1.04%)
At close: Oct 13, 2025, 4:00 PM EDT
102.10
0.00 (0.00%)
After-hours: Oct 13, 2025, 6:30 PM EDT
Integer Holdings Revenue
Integer Holdings had revenue of $476.49M in the quarter ending June 27, 2025, with 11.36% growth. This brings the company's revenue in the last twelve months to $1.79B, up 9.64% year-over-year. In the year 2024, Integer Holdings had annual revenue of $1.72B with 10.35% growth.
Revenue (ttm)
$1.79B
Revenue Growth
+9.64%
P/S Ratio
1.92
Revenue / Employee
$163,164
Employees
11,000
Market Cap
3.58B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.72B | 160.94M | 10.35% |
| Dec 31, 2023 | 1.56B | 224.38M | 16.85% |
| Dec 31, 2022 | 1.33B | 110.20M | 9.02% |
| Dec 31, 2021 | 1.22B | 147.64M | 13.75% |
| Dec 31, 2020 | 1.07B | -184.65M | -14.68% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
ITGR News
- 18 days ago - Integer Announces Conference Call to Discuss Third Quarter 2025 Results - GlobeNewsWire
- 2 months ago - Integer to Present at 2025 Wells Fargo Healthcare Conference on Sept. 4 - GlobeNewsWire
- 2 months ago - Integer Holdings Corporation (ITGR) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Integer Holdings Corporation Reports Second Quarter 2025 Results - GlobeNewsWire
- 3 months ago - Integer Appoints Michael Coyle to Board of Directors - GlobeNewsWire
- 3 months ago - The Best Growth Stocks to Buy - Kiplinger
- 3 months ago - Integer Holdings Corporation Announces Conversion Period for 2.125% Convertible Senior Notes due 2028 - GlobeNewsWire
- 3 months ago - Integer Announces Conference Call to Discuss Second Quarter 2025 Results - GlobeNewsWire